Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Prediction Intervals01:03

Prediction Intervals

2.2K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
2.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

3.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

327
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
327

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-enabled eye-movement and emerging multimodal frameworks for precision dyslexia screening and reading pattern analysis.

Frontiers in medicine·2026
Same author

A hybrid optimized framework with energy shape prior segmentation for brain tumor detection in MRI images.

Digital health·2026
Same author

Digital twin-assisted blockchain IoT security model using contrastive and causal learning techniques.

Scientific reports·2026
Same author

Involvement of the PD-1 pathway in the modulation of immune responses during allergic diseases.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

Diabetic retinopathy severity detection using an improved Whale optimization algorithm and convolutional Kolmogorov-Arnold network.

Frontiers in medicine·2026
Same author

Enhancing E-health system accuracy using Rendezvous Data Processing Model (RDPM) with IoT-cloud integration.

Digital health·2026

Related Experiment Video

Updated: May 31, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

Unveiling diabetes onset: Optimized XGBoost with Bayesian optimization for enhanced prediction.

Muhammad Rizwan Khurshid1, Sadaf Manzoor1, Touseef Sadiq2

  • 1Department of Statistics, Islamia University College, Peshawar, Khyber Pakhtunkhwa, Pakistan.

Plos One
|January 24, 2025
PubMed
Summary

Optimizing XGBoost with Bayesian optimization slightly improved diabetes prediction accuracy. This machine learning approach enhances early diabetes risk identification for personalized prevention strategies.

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

630
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

193

Related Experiment Videos

Last Updated: May 31, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

630
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

193

Area of Science:

  • Machine Learning
  • Computational Biology
  • Medical Informatics

Background:

  • Diabetes affects millions globally, requiring early intervention to prevent complications.
  • Accurate prediction of diabetes onset and progression is challenging due to complex, imbalanced datasets.
  • Advanced machine learning models offer potential solutions for improved predictive accuracy.

Purpose of the Study:

  • To optimize hyperparameters of an XGBoost ensemble model using Bayesian optimization.
  • To compare the performance of Bayesian optimized XGBoost against grid search XGBoost for diabetes prediction.
  • To explore the potential of refined machine learning for personalized diabetes risk assessment.

Main Methods:

  • Utilized Bayesian optimization to fine-tune the hyperparameters of an XGBoost ensemble model.
  • Employed a dataset characterized by complexity and imbalance, typical in diabetes prediction tasks.
  • Evaluated model performance using accuracy, F1-score, and Matthews Correlation Coefficient (MCC).

Main Results:

  • Bayesian optimized XGBoost achieved a marginal improvement in accuracy (97.26%) and MCC (81.18%) compared to grid search XGBoost (97.24% accuracy, 81.02% MCC).
  • Both models demonstrated high performance, with F1-scores of 95.72%.
  • The study highlights the benefit of hyperparameter optimization for enhancing predictive models.

Conclusions:

  • Optimized XGBoost with Bayesian optimization shows promise for improving diabetes risk prediction.
  • This approach can aid in developing personalized prevention strategies, enhancing patient outcomes.
  • Further research and integration into healthcare systems are crucial for widespread adoption.